Australia markets open in 4 hours 16 minutes

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.5500-0.1400 (-8.28%)
As of 02:44PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts4464
Avg. Estimate-0.2-0.2-0.8-0.47
Low estimate-0.25-0.25-1.23-1.01
High estimate-0.13-0.11-0.42-0.09
Year ago EPS-0.63-0.55-1.67-0.8
Revenue estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts4454
Avg. Estimate29.69M32.23M133.94M181.52M
Low estimate27.4M29.3M124M147.1M
High estimate33.2M36.33M149.1M199.7M
Year ago sales23.46M27.63M107.67M133.94M
Sales growth (year/est)26.60%16.60%24.40%35.50%
Earnings history30/03/202229/06/202229/09/202230/12/2022
Est. EPS-0.48-0.5-0.38-0.28
Actual EPS-0.63-0.55-0.38-0.17
Difference-0.15-0.0500.11
Surprise %-31.30%-10.00%0.00%39.30%
EPS trendCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Current estimate-0.2-0.2-0.8-0.47
7 days ago-0.26-0.24-0.85-0.33
30 days ago-0.26-0.24-0.85-0.33
60 days ago-0.26-0.24-0.85-0.33
90 days ago-0.21-0.19-0.87-0.32
EPS revisionsCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Up last 7 days2221
Up last 30 days2221
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A22
Growth estimatesHRTXIndustrySector(s)S&P 500
Current qtr.68.30%N/AN/AN/A
Next qtr.63.60%N/AN/AN/A
Current year52.10%N/AN/AN/A
Next year41.30%N/AN/AN/A
Next 5 years (per annum)47.50%N/AN/AN/A
Past 5 years (per annum)-43.36%N/AN/AN/A